Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;30(10):1893-7.
doi: 10.3174/ajnr.A1739. Epub 2009 Oct 1.

Metachromatic leukodystrophy: a scoring system for brain MR imaging observations

Affiliations

Metachromatic leukodystrophy: a scoring system for brain MR imaging observations

F Eichler et al. AJNR Am J Neuroradiol. 2009 Nov.

Abstract

Background and purpose: Metachromatic leukodystrophy (MLD) is a devastating demyelinating disease for which novel therapies are being tested. We hypothesized that MR imaging of brain lesion involvement in MLD could be quantified along a scale.

Materials and methods: Thirty-four brain MR images in 28 patients with proved biochemical and genetic defects for MLD were reviewed: 10 patients with late infantile, 16 patients with juvenile, and 2 patients with adult MLD. All MR images were reviewed by experienced neuroradiologists and neurologists (2 readers in Germany, 2 readers in the United States) for global disease burden, as seen on the T2 and fluid-attenuated inversion recovery images. A visual scoring method was based on a point system (range, 0-34) derived from the location of white matter involvement and the presence of global atrophy, analogous to the scoring system developed for adrenoleukodystrophy. The readers were blinded to the neurologic findings.

Results: Thirty-three of 34 MR images showed confluent T2 hyperintensities of white matter. The inter-rater reliability coefficient was 0.988. Scores between readers were within 2 points of each other. Serial MR imaging studies in 6 patients showed significant progressive disease in 3 patients (initial score average, 4; mean follow-up, 24.3) and no change or 1 point progression in 3 patients (initial score average, 12; mean follow-up, 12.66). Projection fibers and the cerebellum tended to be involved only in advanced stages of disease.

Conclusions: The MLD MR severity scoring method can be used to provide a measure of brain MR imaging involvement in MLD patients.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Scoring details of the metachromatic leukodystrophy (MLD) MR imaging severity score. Differences between scoring faint (1 point) versus dense appearance (2 points) are shown. A, Periventricular and central involvement in the frontal white matter is categorized as faint (1 point, thin arrow), whereas myelination is preserved in the subcortical U-fibers (0 points, thick arrow). B, Periventricular and central involvement in the frontal white matter is categorized as dense (2 points, thin arrow), and there are areas that lack subcortical U-fiber myelination (2 points, thick arrow). C, Inner atrophy as measured in the third ventricle (arrow).
Fig 2.
Fig 2.
Midline of the corpus callosum in advanced stages of MLD. T2 lesion hyperintensities in the midline are reduced compared with the adjacent supratentorial white matter lesion signal intensity (arrow).
Fig 3.
Fig 3.
Correlation of age and MR imaging severity score in patients with MLD. The greatest variability in MR imaging lesion severity is seen in the first decade of life. Thereafter, most patients have a severity score of >20. Patients with serial scans have scores with connecting lines.

References

    1. Kim TS, Kim IO, Kim WS, et al. MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol 1997;18:733–38 - PMC - PubMed
    1. Faerber EN, Melvin J, Smergel EM. MRI appearances of metachromatic leukodystrophy. Pediatr Radiol 1999;29:669–72 - PubMed
    1. Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15:1761–66 - PMC - PubMed
    1. von Figura K, Giselmann V, Jaeken J. Metachromatic leukodystrophy. In: Scriver CR, Sly WS, Childs A. eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw Hill; 2000:3695–3724
    1. Biffi A, Cesani M, Fumagalli F, et al. Metachromatic leukodystrophy: mutation analysis provides further evidence of genotype-phenotype correlation. Clin Genet 2008;74:349–57. Epub 2008 Sep 11 - PubMed

Publication types